Artículos científicos Open Access
Population Immunity Against COVID-19 in the United States
Seyed M. Moghadas, PhD, Pratha Sah, PhD, Affan Shoukat, PhD, Lauren Ancel Meyers, PhD, Alison P. Galvani, PhD
Annals of Internal Medicine
SARS-like viruses may jump from animals to people hundreds of thousands of times a year
KAI KUPFERSCHMIDT
SCIENCEINSIDER
Can ‘zero COVID’ countries continue to keep the virus at bay once they reopen?
DENNIS NORMILE
SCIENCEINSIDER
Schools have begun mass testing for COVID-19. But hurdles and uncertainties remain
JENNIFER COUZIN-FRANKEL
SCIENCEINSIDER
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
KIZZMEKIA S. CORBETT, et al
Science
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
JOSE MATEUS, et al
Science
Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue
JULIA NIESSL, et al
Science Immunology
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
HYESEON CHO, et al
SCIENCE TRANSLATIONAL MEDICINE
COVID-19 vaccination and unemployment risk: lessons from the Italian crisis
Pieroni, V., Facchini, A. & Riccaboni, M.
Scientific Reports
The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients
Levi, R., Ubaldi, L., Pozzi, C. et al.
Communications Medicine
Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic target
Yamamotoya, T., Nakatsu, Y., Kanna, M. et al.
Scientific Reports
Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020
Bollen, N., Artesi, M., Durkin, K. et al.
Scientific Reports
